A survey recently conducted by Bayer’s Midol brand and the nonprofit Period. found that a significant portion of menstruating ...
It’s not an easy question to answer. While Vertex leads in patient starts, bluebird has activated more treatment centers.
Keytruda is already approved in patients with endometrial carcinoma that is microsatellite instability-high (MSI-H) or ...
After telegraphing more than a hundred potential layoffs in March in connection with plans to stop construction of a massive ...
In response to rapidly declining profits and the downfall of ADHD drug Vyvanse, Takeda is planning to throw 140 billion ...
If a gene therapy is approved in the U.S., patients in Brazil can sue their government to get it cleared for use there. And, ...
Healthcare marketing agency Vue Health has set its sights on a new executive hire to lead its digital transformation. | ...
Industry's sudden decoupling from Chinese CDMOs could harm millions of patients, BIO warns lawmakers
As a biosecurity crackdown on certain Chinese biopharma service providers gains momentum in Washington, the industry trade ...
Novartis slammed for discrediting industry as 'very concerned' panel finds fault with Entresto files
Novartis’ Entresto team has earned the ire of the PMCPA. For the third time in 12 months, the U.K. drug promotion watchdog ...
British biotechs have a new ally in their struggle to secure funding. | British biotechs have a new ally in their struggle to ...
As U.S. drug shortages run rampant, lawmakers are getting creative with their attempts to ease the situation. | Under the ...
In about a year after launching a revamp strategy under CEO Richard Francis, Teva has managed to return its generics business ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results